CHILDHOOD CANCER SURVIVORSHIP CARE OVERVIEW

7 Jan 2022 
20:00-21:30 (UTC +8 | Singapore Time)

06.00-07.30 (UTC -6 | Memphis Time) 

Melissa Hudson

Melissa M. Hudson

St. Jude's Children Research  Hospital

Lecture #1: Introduction to Late Effects

 

By the end of the session, attendees will be able to:

  • Appreciate how childhood cancer treatment affects long-term health

  • Understand the spectrum of late effects of childhood cancer

  • Understand the concept of risk-based survivorship care

Matthew Ehrhardt.png

Matthew Ehrhardt

St. Jude's Children Research  Hospital

Lecture #2: Survivorship Care Planning 

 

By the end of the session, attendees will be able to:

  • Understand the historical context for the development of the survivorship care plan tool

  • Describe the content and purpose of a survivorship care plan 

  • Describe models of survivorship care

  • Identify resources to guide survivorship care

ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 1

21 Jan 2022 

20:00-21:30 (UTC +8 | Singapore Time)

06.00-07.30 (UTC -6 | Memphis Time) 

Daniel Mulrooney.png

Daniel Mulrooney

St. Jude's Children Research  Hospital

Lecture #1: Cardiac Late Effects

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of cardiac late effects in childhood cancer survivors

  • Identify risk factors for cardiac late effects 

  • Understand recommended screening for cardiac late effects

  • Describe the impact of modifiable risk factors on risk of cardiac late effects

Neel Bhatt.png

Neel Bhatt

Fred Hutchinson Cancer Center

Lecture #2: Pulmonary Late Effects

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of pulmonary late effects in childhood cancer survivors

  • Identify risk factors for pulmonary late effects 

  • Understand recommended screening for pulmonary late effects

  • Describe the impact of modifiable risk factors on risk of pulmonary late effects

ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 2

11 Feb 2022 

20:00-21:30 (UTC +8 | Singapore Time)

06.00-07.30 (UTC -6 | Memphis Time) 

Wassim Chemaitilly.png

Wassim Chemaitilly

St. Jude's Children Research  Hospital

Lecture #1: Endocrine Late Effects – Hypothalamic-Pituitary Axis 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of hypothalamic-pituitary axis late effects in childhood cancer survivors

  • Identify risk factors for hypothalamic-pituitary axis late effects

  • Understand recommended screening for hypothalamic-pituitary axis late effect

Stephanie Dixon.png

Stephanie Dixon

St. Jude's Children Research  Hospital

Lecture #2: Metabolic Late Effects – Obesity, Insulin Resistance 

 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of metabolic late effects in childhood cancer survivors

  • Identify risk factors for metabolic late effects

  • Understand recommended screening for metabolic late effects

ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 3

25 Feb 2022 

20:00-21:30 (UTC +8 | Singapore Time)

06.00-07.30 (UTC -6 | Memphis Time) 

Rod Skinner.png

Rod Skinner

Great North Children's Hospital

Lecture #1: Renal and Bladder Late Effects 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of renal and bladder late effects in childhood cancer survivors

  • Identify risk factors for renal and bladder late effects 

  • Understand recommended screening for renal and bladder late effects

  • Describe the impact of modifiable risk factors on risk of renal and bladder late effects

Sharon

Sharon Castellino

Children’s Healthcare of Atlanta

Lecture #2: Hepatic Late Effects 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of hepatic late effects in childhood cancer survivors

  • Identify risk factors for hepatic late effects 

  • Understand recommended screening for hepatic late effects

  • Describe the impact of modifiable risk factors on risk of hepatic late effects

PSYCHOSOCIAL & NEUROCOGNITIVE LATE EFFECTS OF CHILDHOOD CANCER

12 March 2022 

20:00-21:30 (UTC +8 | Singapore Time)

06.00-07.30 (UTC -6 | Memphis Time) 

Yin Ting Cheung.png

Yin Ting Cheung

Chinese University of Hong Kong

Kevin Krull

Kevin Krull

St. Jude's Children Research  Hospital

2022 Speakers.png

Fiona Schulte

University of Calgary

Lecture #1:  Neurocognitive Late Effects After Childhood Cancer

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of neurocognitive late effects in childhood cancer survivors

  • Identify risk factors for neurocognitive late effects

  • Understand recommended screening for neurocognitive late effects

Lecture #2:  Interventions for Neurocognitive Late Effects 

By the end of the session, attendees will be able to:

  • Describe interventions to prevent/remediate neurocognitive deficits in children and adolescents

  • Describe interventions for healthy brain aging in adults treated for childhood cancer

Lecture #3: Psychosocial Outcomes After Childhood Cancer 

 

By the end of the session, attendees will be able to:

  • Describe psychosocial outcomes in childhood cancer survivors

  • Identify risk factors for deficits in psychosocial outcomes

  • Understand recommended screening and interventions to optimize psychosocial outcomes

ORGAN HEALTH AFTER CHILDHOOD CANCER
PART 4

25 March 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Sogol Mostoufi-Moab.png

Sogol Mostoufi-Moab

 Children's Hospital of Philadelphia

Lecture #1: Late Effects on Bone Health: Bone Mineral Density  

By the end of the session, attendees will be able to:

  • Describe the prevalence of bone mineral density deficits in childhood cancer survivors

  • Identify risk factors for osteopenia/osteoporosis

  • Understand recommended screening for bone mineral density deficits

Seth Karol.png

Seth Karol

St. Jude's Children Research  Hospital

Lecture #2: Late Effects on Bone Health – Osteonecrosis

 

By the end of the session, attendees will be able to:

  • Describe the prevalence of osteonecrosis in childhood cancer survivors

  • Identify risk factors for osteonecrosis

  • Understand recommended screening for osteonecrosis

REPRODUCTIVE LATE EFFECTS AND PREGNANCY OUTCOMES

8 April 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Jennifer Levine.png

Jennifer Levine

Weill Cornell Medicine

Lecture #1: Reproductive Late Effects in Female Cancer Survivors

By the end of the session, trainees will be able to:

  • Describe the prevalence and type of reproductive late effects female childhood cancer survivors

  • Identify risk factors of infertility and adverse pregnancy outcomes

  • Understand recommended screening for reproductive late effects

  • Appreciate options for fertility preservation

Dan Green.png

Daniel Green

St. Jude's Children Research  Hospital

Lecture #2: Reproductive Late Effects in Male Cancer Survivors

By the end of the session, trainees will be able to:

  • Describe the prevalence and type of reproductive late effects male childhood cancer survivors

  • Identify risk factors of infertility and adverse pregnancy outcomes

  • Understand recommended screening for reproductive late effects

  • Appreciate options for fertility preservation

SUBSEQUENT NEOPLASMS AFTER CHILDHOOD CANCER

22 April 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Lucie Turcotte.png

Lucie Turcotte

University of Minnesota

Lecture #1: Subsequent Malignant Neoplasms Overview

By the end of the session, attendees will be able to:

  • Define the subsequent malignant neoplasms in childhood cancer survivors

  • Describe the onset of subsequent malignant neoplasm over the lifespan

  • Describe the burden of subsequent malignant neoplasms in survivors of childhood cancer

  • Identify risk factors for the development of common subsequent malignant neoplasms

Matthew Ehrhardt.png

Matthew Ehrhardt

St. Jude's Children Research  Hospital

Lecture #2: Cancer Screening Guidelines After Childhood Cancer

By the end of the session, attendees will be able to:

  • Describe treatment-related risk factors for specific subsequent malignant neoplasms (breast, thyroid, colon, skin, hematologic)

  • Understand recommended screening for common subsequent malignant neoplasms

  • Understand differences between recommendations for high-risk cancer survivors and the general population cancer screening recommendations.

  • Describe recommended health behaviors for cancer prevention

NEUROLOGIC LATE EFFECTS AFTER CHILDHOOD CANCER

6 May 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Zsila Sadighi.png

Zsila Sadighi

The University of Texas MD Anderson Cancer Center

2022 Speakers.png

Daniel Bowers

University of Texas

Lecture #1:  Neurologic Late Effects After Childhood Cancer

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of neurologic late effects in childhood cancer survivors

  • Identify risk factors for neurologic late effects

  • Understand recommended screening for neurologic late effects

Lecture #2: Stroke After Childhood Cancer

By the end of the session, attendees will be able to:

  • Describe the prevalence of stroke in childhood cancer survivors

  • Identify risk factors for stroke

  • Describe the impact of modifiable risk factors on risk of stroke

NEUROSESORY LATE EFFECTS AFTER CHILDHOOD CANCER

20 May 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Mary Ellen Hoehn.png

Mary Ellen Hoehn

St. Jude's Children Research  Hospital

Lecture #1: Ocular Late Effects After Childhood Cancer 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of ocular late effects in childhood cancer survivors

  • Identify risk factors for ocular late effects

  • Understand recommended screening for visual and ocular late effects

Wendy Landier

Wendy Landier

University of Alabama

Lecture #2: Auditory Late Effects After Childhood Cancer 

 

By the end of the session, attendees will be able to:

  • Describe the prevalence and type of auditory late effects in childhood cancer survivors

  • Identify risk factors for auditory late effects

  • Understand recommended screening for auditory late effects​

PSYCHOSOCIAL LATE EFFECTS OF CHILDHOOD CANCER PART 1

3 June 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

Tara Brinkman.png

Tara Brinkman

St. Jude's Children Research  Hospital

Lecture #1: Functional and Social Outcomes After Childhood Cancer

 

By the end of the session, attendees will be able to:

  • Describe functional and social outcomes in childhood cancer survivors

  • Identify risk factors for deficits in social and functional outcomes

  • Understand recommended screening and interventions to optimize functional and social outcomes

Kirsten Ness.png

Kirsten Ness

St. Jude's Children Research  Hospital

Lecture #2: Rehabilitation Across the Cancer Care Continuum

By the end of the session, attendees will be able to:

  • Identify targets for rehabilitation in childhood cancer patients and long-term survivors

  • Describe rehabilitation strategies and programs used in cancer patients and long-term survivors

  • Appreciate adaptations that may enhance success in rehabilitation

PSYCHOSOCIAL LATE EFFECTS OF CHILDHOOD CANCER PART 2

17 June 2022 

20:00-21:30 (UTC +8 | Singapore Time)

07.00-08.30 (UTC -6 | Memphis Time) 

2022 Speakers.png

Jordan Gilleland Marchak

Emory University School of Medicine

Lecture #1:  Mental Health After Childhood Cancer

By the end of the session, attendees will be able to:

  • Describe mental health outcomes in childhood cancer survivors

  • Identify risk factors for mental health impairment

  • Understand recommended screening for mental health impairment

  • Describe interventions to support mental health in survivors of childhood cancer

Rachel Tillery Webster.png

Rachel Tillery Webster

St. Jude's Children Research  Hospital

Lecture #2: The Effect of Childhood Cancer on Families and Siblings

By the end of the session, attendees will be able to:

  • Describe perspectives of siblings and families affected by childhood cancer 

  • Understand how childhood cancer affects long term health and functioning of families and siblings

  • Appreciate resources to support families and siblings affected by childhood cancer